Quoin Pharmaceuticals - QNRX Competitors

Ra Medical Systems (NYSE:RMED) and Quoin Pharmaceuticals (NASDAQ:QNRX) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their community ranking, profitability, valuation, institutional ownership, dividends, risk, media sentiment, analyst recommendations and earnings.

Which has more volatility & risk, RMED or QNRX?

Ra Medical Systems has a beta of 1.08, meaning that its stock price is 8% more volatile than the S&P 500. Comparatively, Quoin Pharmaceuticals has a beta of 1.63, meaning that its stock price is 63% more volatile than the S&P 500.

Do analysts rate RMED or QNRX?

Ra Medical Systems presently has a consensus price target of $12.00, suggesting a potential upside of 7,172.73%. Quoin Pharmaceuticals has a consensus price target of $50.00, suggesting a potential upside of 918.33%. Given Ra Medical Systems' higher possible upside, analysts plainly believe Ra Medical Systems is more favorable than Quoin Pharmaceuticals.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ra Medical Systems	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Quoin Pharmaceuticals	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the media favor RMED or QNRX?

In the previous week, Quoin Pharmaceuticals had 1 more articles in the media than Ra Medical Systems. MarketBeat recorded 4 mentions for Quoin Pharmaceuticals and 3 mentions for Ra Medical Systems. Quoin Pharmaceuticals' average media sentiment score of 1.28 beat Ra Medical Systems' score of -1.00 indicating that Quoin Pharmaceuticals is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ra Medical Systems	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
Quoin Pharmaceuticals	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Which has higher earnings and valuation, RMED or QNRX?

Quoin Pharmaceuticals has lower revenue, but higher earnings than Ra Medical Systems.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ra Medical Systems	$20 thousand	266.48	-$25.07 million	-$2.43	-0.07
Quoin Pharmaceuticals	N/A	N/A	-$21.46 million	N/A	N/A

Do insiders & institutionals have more ownership in RMED or QNRX?

2.8% of Ra Medical Systems shares are held by institutional investors. Comparatively, 21.7% of Quoin Pharmaceuticals shares are held by institutional investors. 1.0% of Ra Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Is RMED or QNRX more profitable?

Quoin Pharmaceuticals has a net margin of 0.00% compared to Ra Medical Systems' net margin of -110,533.34%. Quoin Pharmaceuticals' return on equity of 0.00% beat Ra Medical Systems' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ra Medical Systems	-110,533.34%	-146.71%	-108.87%
Quoin Pharmaceuticals	N/A	N/A	-355.59%

Does the MarketBeat Community favor RMED or QNRX?

Ra Medical Systems received 85 more outperform votes than Quoin Pharmaceuticals when rated by MarketBeat users. However, 75.00% of users gave Quoin Pharmaceuticals an outperform vote while only 57.89% of users gave Ra Medical Systems an outperform vote.

Company	Underperform	Outperform
Ra Medical Systems	Outperform Votes 88 57.89%	Underperform Votes 64 42.11%
Quoin Pharmaceuticals	Outperform Votes 3 75.00%	Underperform Votes 1 25.00%

Summary

Quoin Pharmaceuticals beats Ra Medical Systems on 9 of the 14 factors compared between the two stocks.